TRADING UPDATES: Mattioli outlook promising; virus hits Grand Vision
TRADING UPDATES: Mattioli outlook promising; virus hits Grand Vision
Read moreTRADING UPDATES: Mattioli outlook promising; virus hits Grand Vision
Read moreTRADING UPDATES: Hunting hurt by Ida; React revenue short of consensus
Read moreUK shareholder meetings calendar - next 7 days
Read moreIN BRIEF: MaxCyte Chair Thompson to step down late October
Read moreIN BRIEF: MaxCyte to join Russell 2000 index in US on September 20
Read moreTRADING UPDATES: Strong annual results from Springfield, Fiske
Read moreUK earnings, trading statements calendar - next 7 days
Read moreTRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million
Read moreIN BRIEF: MaxCyte underwriters exercise over-allotment option
Read moreTRADING UPDATES: Cambria Automobiles suitor tables improved offer
Read more(Sharecast News) - Cell engineering technology company MaxCyte announced the pricing of its upsized offering of 13,500,000 shares on Nasdaq on Friday, at a price of $13.00 per share.
Read moreTRADING UPDATES: Attraqt and tinyBuild trade in line in first half
Read moreIN BRIEF: MaxCyte makes administrative changes ahead of Nasdaq listing
Read moreUK shareholder meetings calendar - next 7 days
Read moreEXECUTIVE CHANGES: Keywords Studies CEO Day retires after 12 years
Read more